A 133 (Bupropion Extended Release (SR) 150 mg)
Pill imprint A 133 has been identified as Bupropion hydrochloride extended release (SR) 150 mg.
Bupropion is used in the treatment of depression; smoking cessation; seasonal affective disorder; postural orthostatic tachycardia syndrome; premenstrual dysphoric disorder (and more), and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for A 133 (Bupropion Extended Release (SR) 150 mg)
- 150 mg
- 11.00 mm
- Prescription only
- Drug Class:
- Miscellaneous antidepressants
Smoking cessation agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- National Drug Code (NDC):
- Inactive Ingredients:
silicon dioxide colloidal
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|68084-0471||Amerisource Health Services|
|18837-0246||Innoviant Pharmacy Inc (repackager)|
Note: Inactive ingredients may vary.
Bupropion hydrochloride extended release (SR) is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...